| eResearchTechnology, Inc. (NASDAQ:ERES) , a leading provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today that its Chief Financial Officer, Bruce Johnson, will present at the 17th annual Roth Capital Partners Growth Stock Conference at 12 noon PST on February 23, 2005. |
PHILADELPHIA, Feb. 14 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (NASDAQ:ERES) , a leading provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today that its Chief Financial Officer, Bruce Johnson, will present at the 17th annual Roth Capital Partners Growth Stock Conference at 12 noon PST on February 23, 2005. The conference is hosted by the St. Regis Monarch Beach Resort in Dana Point, Calif.
Interested parties can visit http://www.ert.com/ to access a web cast presentation.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/), is a provider of integrated software applications and technology consulting services to the pharmaceutical, biotechnology and medical device industries. The company is also a market leader in providing centralized core-diagnostic electrocardiographic services on a global basis. The company offers Internet and other technology-based solutions designed to streamline the clinical trials process by enabling its customers to automate many parts of a clinical trial.
Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Forms 10-K and 10-Q filed with the Securities and Exchange Commission.
Source: eResearchTechnology, Inc.
|